Delivery Order SPE2DR25D3010-SPE2DR26F88HM
Award Date 12/22/25
Potential Completion Date 12/23/25
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,672.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on September 5, 2025, with completion targeted for September 8, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Crexont ER 87.5 mg-350 mg capsules (120 count) with a ceiling value of $3,224.67. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical product will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $3,642.37 delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Crexont ER 70 MG-280 MG capsules (120-count). The contract is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at the...
- The Defense Logistics Agency awarded a $2,881.19 delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on August 21, 2025, with ultimate completion by August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract utilizing competitively-awarded pricing. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Crexont ER (a pharmaceutical product available in 87.5 mg-350 mg capsules, quantity 120) with a ceiling value of $3,260.55. This firm fixed price delivery order, with an ultimate completion date of December 18, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.79 to AmerisourceBergen Drug Corp for Crexont ER 70 mg-280 mg capsules (120 count). This non-set-aside, firm fixed-price delivery order was executed on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,342.98 to AmerisourceBergen Drug Corp for the supply of Crexont ER 70 mg-280 mg capsules (120 count) on July 21, 2025, with ultimate completion scheduled for July 22, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,303.83 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 MG-350 MG capsules (120 count) on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the contractor's critical role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,192.05 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 mg-350 mg capsules (120-count supply). This is a firm fixed-price delivery order with no set-aside designation, completed on September 3, 2025, and performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its...
- The Defense Logistics Agency awarded a $1,231.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for CREXONT ER 70 mg-280 mg capsules (120-count supply). This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 28, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...